Looking through to 2027, UBS upgrades ‘quality compounder’ ASML to buy
Short excerpt below. Click through to read at the original source.
UBS analysts recommend investors focus on the 20% eps CAGR ASML is expected to deliver between 2027 and 2030
Short excerpt below. Click through to read at the original source.
UBS analysts recommend investors focus on the 20% eps CAGR ASML is expected to deliver between 2027 and 2030